Cannabinoids in MS—are we any closer to knowing how best to use them?

Abstract

Get full access to this article

View all access options for this article.

References

Iversen L. Cannabis and the brain . Brain 2003; 126: 1252-1270 .

Bowling AC.

Worthless weed or pot of gold?

Int J MS Care 2003; 5: 138-166 .

Katona S , Kaminski E , Sanders H , Zajicek J. Cannabinoid influence on cytokine profile in multiple sclerosis . Clin Exper Immunol 2005; 140: 580-585 .

Chong MS , Wolff K , Wise K , Tanton C , Winstock A , Silber E. Cannabis use in patients with multiple sclerosis . Mult Scler 2006; 5: 646-651 .

Wade DT , Makela PM , House H , Bateman C , Robson P. Long-term use of a cannabis-based medicine in the treatment of spasticity and other symptoms of multiple sclerosis . Mult Scler 2006; 12: 639-645 .

Barnes MP. Sativex: clinical efficacy and tolerability in the treatment of symptoms of multiple sclerosis and neuropathic pain . Expert Opin Pharmacother 2006; 12: 607-615 .

Clark AJ , Ware MA , Yazer E , Murray TJ , Lynch ME. Patterns of cannabis use among patients with multiple sclerosis . Neurol 2004; 62: 2098-2100 .

Smith PF. Cannabinoids as potential anti-epileptic drugs . Curr Opin Investig Drugs 2005; 6: 680-685 .

Zajicek J , Fox P , Sanders H , Wright D , Vickery J , Nunn A , et al. Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomized placebo-controlled trial . Lancet 2003; 362: 1517-1526 .

10.

Freeman RM , Adekanmi O , Waterfield MR , Water-field AE , Wright D , Zajicek J. The effect of cannabis on urge incontinence in patients with multiple sclerosis: a multicentre, randomized placebo-controlled trial (CAMS-LUTS) . Int Urogynecol J 2006; published online March 22, 2006.

11.

Zajicek JP , Sanders HP , Wright DE , Vickery PJ , Ingram WM , Reilly SM , et al. Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up . J Neurol Neurosurg Psych 2005;76: 1664-1669 .

12.

Witting A , Chen L , Cudaback E , Straiker A , Walter L , Rickman B , et al. Experimental autoimmune encephalomyelitis disrupts endocannabinoid-mediated neuroprotection . Proc Natl Acad Sci USA 2006; 103: 6362-6367 .

13.

Killestein J , Hoogervorst ELJ , Reif M , Blauw B , Smits M , Uitdehaag BMJ , et al. Immunomodulatory effects of orally administered cannabinoids in multiple sclerosis . J Neuroimmunol 2003; 137: 140-143 .